{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:07:56Z","timestamp":1762927676054,"version":"3.45.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Neoadjuvant chemotherapy plays a vital role in the treatment of pancreatic ductal adenocarcinoma (PDAC), but treatment effect complicates pathologic examination of postneoadjuvant Whipple resections. Institutional practice is variable but current Pancreatobiliary Pathology Society (PBPS) guidelines suggest extensive microscopic examination of the tumor bed (TB). In practice, gross identification of TB is challenging and may lead to an inaccurate assessment of tumor size. The purpose of this study is to evaluate the adequacy of current practice in postneoadjuvant Whipple resections for pathologic staging. A single institutional prospective cohort was assessed, including 29 entirely submitted (ES) specimens and 10 current PBPS guideline-based (CG) specimens. Cases were evaluated for TB gross measurement, TB microscopic tumor, nontumor bed (N-TB) microscopic tumor, overall size assessment by microscopic evaluation, and presence of lymph nodes with metastases. ES and CG specimens showed similar overall residual tumor size measurements under the current PBPS guidelines protocol, but with the entire submission, tumor size increased by an average of 0.5\u00a0cm (range: 0.0 to 2.1\u00a0cm). Twenty-eight percent had an upstaged ypT due to a significant N-TB tumor. These findings delineate the limitations of gross TB assessment in postneoadjuvant Whipple resections for adequate pathologic staging and appropriate prognostication.<\/jats:p>","DOI":"10.1097\/pas.0000000000002465","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:00:10Z","timestamp":1756288810000},"page":"1207-1215","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Postneoadjuvant Whipple Resections Show Significant Residual Microscopic Tumor Beyond Grossly Identified Tumor Bed"],"prefix":"10.1097","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4438-0431","authenticated-orcid":false,"given":"Komson","family":"Wannasai","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony R.","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuti G.","family":"Shroff","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan N.","family":"Glickman","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Mattia","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Lisa","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria L.","family":"Ganci","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Rider","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernandez-del Castillo","family":"Carlos","sequence":"additional","affiliation":[{"name":"Department of Surgery, Massachusetts General Hospital"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Mino-Kenudson","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8945-5997","authenticated-orcid":false,"given":"Angela R.","family":"Shih","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"R1-20251112","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.gastro.2020.10.007","article-title":"Worldwide burden of, risk factors for, and trends in pancreatic cancer","volume":"160","author":"Huang","year":"2021","journal-title":"Gastroenterol"},{"key":"R3-20251112","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N Engl J Med"},{"key":"R4-20251112","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2013.279201","article-title":"Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial","volume":"310","author":"Oettle","year":"2013","journal-title":"JAMA"},{"key":"R5-20251112","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MPA.0000000000000314","article-title":"FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer","volume":"44","author":"Petrelli","year":"2015","journal-title":"Pancreas"},{"key":"R6-20251112","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J Clin Oncol"},{"key":"R7-20251112","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/SLA.0000000000000867","article-title":"Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer","volume":"261","author":"Ferrone","year":"2015","journal-title":"Ann Surg"},{"key":"R8-20251112","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/SLA.0000000000001763","article-title":"Multi-institutional validation study of the American Joint Commission on Cancer 8th Editionx changes for T and N staging in patients with pancreatic adenocarcinoma","volume":"265","author":"Allen","year":"2017","journal-title":"Ann Surg"},{"key":"R9-20251112","first-page":"418","article-title":"Multinational validation of the American Joint Committee on Cancer 8th edition pancreatic cancer staging system in a pancreas head cancer cohort","volume":"25","author":"Kwon","year":"2018","journal-title":"J HepatoBiliaryPancreat Sci"},{"key":"R10-20251112","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1245\/s10434-016-5093-7","article-title":"Pancreatic ductal adenocarcinoma is spread to the peripancreatic soft tissue in the majority of resected cases, rendering the AJCC T-Stage protocol (7th edition) inapplicable and insignificant: a size-based staging system (pT1: \u22642, pT2: >2\u2013\u22644, pT3: >4 cm) is more valid and clinically relevant","volume":"23","author":"Saka","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R11-20251112","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/PAS.0000000000000887","article-title":"Prognostic significance of new AJCC tumor stage in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy","volume":"41","author":"Chatterjee","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R12-20251112","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/his.14067","article-title":"Microscopic size measurements in post-neoadjuvant therapy resections of pancreatic ductal adenocarcinoma (PDAC) predict patient outcomes","volume":"77","author":"Zhang","year":"2020","journal-title":"Histopathol"},{"key":"R13-20251112","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/PAS.0000000000001853","article-title":"Pathologic examination of pancreatic specimens resected for treated pancreatic ductal adenocarcinoma","volume":"46","author":"Wang","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R15-20251112","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2559.2005.02176.x","article-title":"Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer","volume":"47","author":"Ryan","year":"2005","journal-title":"Histopathol"},{"key":"R16-20251112","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000065089","article-title":"Intraductal spread of pancreatic cancer","volume":"2","author":"Yamasaki","year":"2002","journal-title":"Pancreatol"},{"key":"R17-20251112","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1038\/s41379-020-0572-6","article-title":"Intraductal pancreatic cancer is less responsive than cancer in the stroma to neoadjuvant chemotherapy","volume":"33","author":"Fujikura","year":"2020","journal-title":"Mod Pathol"},{"key":"R18-20251112","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00006676-200201000-00003","article-title":"Perineural invasion in pancreatic cancer","volume":"24","author":"Hirai","year":"2002","journal-title":"Pancreas"},{"key":"R19-20251112","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.hpb.2021.01.003","article-title":"Prognostic significance of residual lymphovascular invasion after resection of locally advanced and borderline resectable pancreatic adenocarcinomas treated by neoadjuvant chemotherapy","volume":"23","author":"Addeo","year":"2021","journal-title":"HPB"},{"key":"R20-20251112","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3390\/jcm11092367","article-title":"Perineural invasion in pancreatic ductal adenocarcinoma (PDAC): a saboteur of curative intended therapies?","volume":"11","author":"Felsenstein","year":"2022","journal-title":"J Clin Med"},{"key":"R21-20251112","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/SLA.0000000000003763","article-title":"Postoperative chemotherapy benefits patients who received preoperative therapy and pancreatectomy for pancreatic adenocarcinoma","volume":"271","author":"Perri","year":"2019","journal-title":"Ann Surg"},{"key":"R22-20251112","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/jamaoncol.2020.3537","article-title":"Evaluation of adjuvant chemotherapy in patients with resected pancreatic cancer after neoadjuvant FOLFIRINOX treatment","volume":"6","author":"van Roessel","year":"2020","journal-title":"JAMA Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002465","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:00:23Z","timestamp":1762927223000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002465"}},"subtitle":["Implications for Accurate Tumor Staging"],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002465","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"type":"print","value":"0147-5185"},{"type":"electronic","value":"1532-0979"}],"subject":[],"published":{"date-parts":[[2025,8,27]]}}}